Global Anal Fissure Treatment Market Insights Forecasts to 2033

• The Global Anal Fissure Treatment Market Size was Valued at USD 1161.3 Million in 2023
• The Market Size is Growing at a CAGR of 5.51% from 2023 to 2033
• The Worldwide Anal Fissure Treatment Market Size is Expected to Reach USD 1986.1 Million by 2033
• Asia Pacific is Expected to Grow the fastest during the forecast period.

The Global Anal Fissure Treatment Market Size is Anticipated to Exceed USD 1986.1 Million by 2033, Growing at a CAGR of 5.51% from 2023 to 2033.

Market Overview

An anal fissure is a crack or tear in the lining of the anal canal. Anal pain and rectal bleeding are the most common causes of anal fissures, particularly during bowel movements. Anul trauma generally causes a fissure, especially from straining to pass hard stools. Anal fissures can happen suddenly or moderately. They can also heal quickly or slowly. Anal fissures are very common, particularly in newborns and pregnant women. The most common symptoms of an anal fissure seem to be acute pain when pooping, fresh, red blood in poop, and burning or itching with pooping. Few people may lump on the skin near the tear and anal muscle spasms. primary causes of anal fissures, such as obstructed defecation syndrome, infant dyschezia, childbirth, chronic constipation and straining to poop, and penetration. Other pitching conditions involve anal cancer, prior surgery, tuberculosis, sexually transmitted infections, inflammatory bowel disease, and diaper rash. Various types of treatments are involved in anal fissure treatment, like topical nitroglycerin, stool softeners, calcium channel blockers, surgery, and others. The rising consumption of junk and unhealthy foods and increasing medical-associated costs for infrastructure development are the major factors driving market growth.

Report Coverage

This research report categorizes the market for the global anal fissure treatment market based on various segments and regions forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the global anal fissure treatment market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the global anal fissure treatment market.

Driving Factors

Increasing cases of anal fissures are the main factor driving the growth of the global anal fissure treatment market. The rising awareness among patients regarding anal fissure treatment choices. Healthcare professionals are helping train patients that anal fissure is a common medical condition and that there are successful solutions available. The social stigma previously linked to anal disorders is being minimized. This is inspiring more patients to look for timely medical care, thus propelling the expansion of the market. Educational efforts by healthcare workers are also enhancing awareness. Additionally, the availability of novel treatment choices and advanced diagnostic techniques, like laser therapy and minimally invasive procedures, is propelling the growth of the market.

Restraining Factors

Looking for medical care for anal fissure disorders is still linked to discomfort and social taboo in some areas of society. This minimizes the patient’s visit to the physician to get checked, leading to underestimating and undertreatment. Social stigma is more common in developing nations and rural areas. Furthermore, defined treatments for anal fissures may be connected with side effects or complications that can hamper the acquisition of particular therapies and impact market expansion. In addition, rising product recalls by market players due to contamination in the products are anticipated to restrain the growth of the market over the forecast period.

Market Segmentation

The global anal fissure treatment market share is classified into treatment type, route of administration, and end-user.

• The surgery segment is anticipated to hold the largest share of the global anal fissure treatment market during the forecast period.    

On the basis of the treatment type, the global anal fissure treatment market is divided into medication and surgery. Among these, the surgery segment is anticipated to hold the largest share of the global anal fissure treatment market during the forecast period. The increasing number of fistula-induced infections and the growing impulse for safe and effective treatment. Surgical interference may be suggested for chronic or severe anal fissures that do not respond to conventional treatments. Processes like lateral internal sphincterotomy and anal advancement flaps help to relax the anal sphincter and assist healing.

• The oral segment is anticipated to hold the highest share of the global anal fissure treatment market during the forecast period.

On the basis of the route of administration, the global anal fissure treatment market is divided into oral, topical, and others. Among these, the oral segment is anticipated to hold the highest share of the global anal fissure treatment market during the forecast period. Among the oral drugs are laxatives, analgesics, calcium channel blockers, and stool softeners. The majority of these drugs are easily available over-the-counter. Laxatives are often used to treat constipation in the pediatric population. Over 3% of children around the world suffer from functional constipation, whereas 10–23% of cases are predicted in North and South America.

• The hospitals & clinics segment is anticipated to hold the largest share of the global anal fissure treatment market during the forecast period.

On the basis of end-user, the global anal fissure treatment market is divided into hospitals & clinics and research & academic institutes. Among these, the hospitals & clinics segment is anticipated to hold the largest share of the global anal fissure treatment market during the forecast period. The cost-effective treatment substitute compared to other groups, hospitals & clinics hold the largest share. Anal fissures can also be detected during a standard health check-up by any physician; therefore, no specific tests or diagnoses are required. Due to this, many people go for early therapy at home, which further increases the acquisition rate among people who pick self-treatment methods.

Regional Segment Analysis of the Global Anal Fissure Treatment Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

North America is anticipated to hold the largest share of the global anal fissure treatment market over the predicted timeframe.

North America is anticipated to hold the largest share of the global anal fissure treatment market over the predicted timeframe. The expansion of the market in North America is due to the large number of cases of constipation and sedentary lifestyles in the region. In addition, the US anal fissure treatment market holds the highest market share, and the Canadian anal fissure treatment market is the fastest-growing market in the North American region. The Administration for Community Living evaluates that percentage. Furthermore, the factors propelling the growth of the market involve the acquisition of a sedentary lifestyle and an increase in the consumption of unhealthy foods. All over the world, 28% of adults, or 1.4 billion people, are living a sedentary lifestyle, which is more than 1 in 4 adults. These factors drive the growth of the anal fissure treatment market over the predicted timeframe.

Asia-Pacific is anticipated to grow at the fastest rate in the global anal fissure treatment market over the predicted timeframe. Asia Pacific grows at the fastest rate because of the presence of a few generic manufacturers and the technical improvements and advanced products being established by pharmaceutical and biotechnology companies every year. As per the National Investment Promotion and Facilitation Agency, Indian pharmaceutical companies manufacture around 60,000 generic brands across 60 therapeutic areas, such as generic drugs, OTC drugs, API/bulk drugs, and others. Additionally, increasing healthcare funding in the Asia-Pacific region will further expand market growth. These factors drive the growth of the anal fissure treatment market over the predicted timeframe in this region.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the global anal fissure treatment market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Teva Pharmaceutical Industries Ltd.
• Cook
• Eisai Co Ltd.
• Bayer AG
• Allergan Inc.
• Taro Pharmaceutical Inc.
• Pfizer Inc.
• GlaxoSmithKline Plc.
• Cigna
• Abbott Laboratories
• AstraZeneca
• Valeant Pharmaceuticals International Inc.
• Cipla Inc.
• Sanofi
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent Developments

• In July 2023, Acrux Limited, a pharmaceutical industry, declared that the U.S. Food and Drug Administration (FDA) has received Acrux’s application for a generic version (abbreviated New Drug Application, or ANDA) of Nitroglycerin Ointment, 0.4, for review. Nitroglycerin Ointment, 0.4%, is used to treat moderate to severe pain related to chronic anal fissures.

• In March 2022, to treat refractory perianal fistulas in Crohn’s disease patients, Ossium Health, Inc. submitted an Investigational New Drug (IND) application to the US Food and Drug Administration (FDA). The OSSM-001 mesenchymal stem cell (MSC) product was the subject of this application.

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the global anal fissure treatment market based on the below-mentioned segments: 

Global Anal Fissure Treatment Market, By Treatment Type

• Medication
• Surgery

Global Anal Fissure Treatment Market, By Route of Administration

• Oral
• Topical
• Others

Global Anal Fissure Treatment Market, By End-User

• Hospitals & Clinics
• Research & Academic Institutes

Global Anal Fissure Treatment Market, By Regional

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • Uk
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa